Zeria Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zeria Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
Towa Pharmaceutical Company Limited
sales of 82.12 billion Japanese Yen [US$817.87 million]
of which 100%
was Pharmaceutical Business),
Aska Pharmaceutical Company Limited
(43.22 billion Japanese Yen [US$430.42 million]
of which 90%
was Pharmaceutical Products Business), and
Fuso Pharmaceutical Industries Ltd
(45.75 billion Japanese Yen [US$455.69 million]
Zeria Pharmaceutical Co Ltd reported sales of ¥62.48 billion (US$622.25 million)
March of 2016.
increase of 2.4%
versus 2015, when the company's sales were ¥61.01 billion.
Sales of Consumer Healthcare Business saw an increase
that was more than double the company's growth rate: sales were up
6.1% in 2016, from
¥27.10 billion to ¥28.74 billion.
Not all segments of Zeria Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Other fell 3.4% to ¥152.56 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Zeria Pharmaceutical Co Ltd also experienced decreases in sales in
Pharmaceuticals Business (down 0.5% to ¥33.58 billion)